Details of issuance or disposal
Issuance of new shares through the partial exercise of Series 21 Stock Acquisition Rights
18,000,000 common shares
The lower thin line represents the existing number of shares to which these shares will be added.
¥522,000,000
Approximately 5.89% (18,000,000 shares issued through the exercise ÷ 305,356,980 total issued shares before the exercise)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of new shares through the partial exercise of Series 21 Stock Acquisition Rights |
| Number of shares to be issued or disposed of | 18,000,000 common shares |
| Issue price and disposal price | ¥29 per share |
| Total issue value | ¥522,000,000 |
| Amount of funds to be raised | Total payment amount: ¥522,000,000; estimated net proceeds: Not disclosed |
| Intended allottee | ORCHID PLUS PTE.LTD., partial exercise of 180,000 units |
| Dilution Rate | Approximately 5.89% (18,000,000 shares issued through the exercise ÷ 305,356,980 total issued shares before the exercise) |
| Total number of issued shares | 305,356,980 shares → 323,356,980 shares（Approximately 5.89%） |
| Exercise price | Initial exercise price: ¥29 per share; adjustment provisions and adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 565,720 units; exercised this time: 180,000 units; remaining after exercise: 385,720 units |
| Most recent equity financing | Timing 9 August 2024 / Type 21st Stock Acquisition Rights issued through a third-party allotment / Amount Not disclosed |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Stated capital increased as a result of the partial exercise of the Series 21 Stock Acquisition Rights by ORCHID PLUS PTE.LTD., the allottee.